Activated eosinophils elicit substance P release from cultured dorsal root ganglion neurons.
This study was performed to test the hypothesis that activated eosinophils or their secretory products can directly stimulate sensory neurons to release their neuropeptides. Neurons derived from neonatal rat dorsal root ganglia (DRG), which synthesize and store sensory neuropeptides, were placed in primary cell culture and were exposed to eosinophils or their bioactive mediators. The resultant release of substance P (SP) was measured by enzyme-linked immunosorbent assay and was expressed as a percent (mean +/- SE) of total neuronal SP content. Eosinophils were isolated from human volunteers with a history of allergic rhinitis and/or mild asthma and were activated by incubation with cytochalasin B (5 micrograms/ml) and N-formyl-methionyl-leucyl-phenylalanine (FMLP, 1 microM). Activated eosinophils [6 x 10(6)/ml, suspended in Hanks' buffered salt solution (HBSS)] applied to cultured DRG neurons for 30 min increased basal SP release 2.4-fold compared with HBSS-exposed neurons (activated eosinophils 11.10 +/- 2.48% vs. HBSS 4.59 +/- 0.99%; P = 0.002), whereas neither nonactivated eosinophils nor cytochalasin B and FMLP in HBSS influenced SP release. Additional cultured DRG neurons were exposed to soluble products made by eosinophils. Compared with SP release under control conditions (2.37 +/- 0.34%), major basic protein (MBP) increased release in a concentration-related fashion (e.g., 3 microM MBP: 6.23 +/- 0.67%, P = 0.006 vs. control), whereas neither eosinophil cationic protein (3 microM), eosinophil-derived neurotoxin (3 microM), leukotriene D4 (500 nM), platelet-activating factor (100 nM), nor H2O2 (100 microM) affected SP release. These studies demonstrate that activated eosinophils can stimulate cultured DRG neurons directly and suggest that MBP may be the responsible mediator.
Garland
A
A
Department of Medicine, University of Chicago, Illinois 60637, USA.
Necheles
J
J
White
S R
SR
Neeley
S P
SP
Leff
A R
AR
Carson
S S
SS
Alger
L E
LE
McAllister
K
K
Solway
J
J
D000818:Animals; D000831:Animals, Newborn; D001249:Asthma / Q000097:blood; D002211:Capsaicin / Q000494:pharmacology; D002478:Cells, Cultured; D018920:Coculture Techniques; D003571:Cytochalasin B / Q000494:pharmacology; D004797:Enzyme-Linked Immunosorbent Assay; D004804:Eosinophils / Q000187:drug effects / Q000502:physiology*; D005727:Ganglia, Spinal / Q000502:physiology*; D006801:Humans; D004676:Myelin Basic Protein / Q000494:pharmacology; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000494:pharmacology; D009474:Neurons / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D010972:Platelet Activating Factor / Q000494:pharmacology; D011107:Polylysine / Q000494:pharmacology; D011189:Potassium Chloride / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D006255:Rhinitis, Allergic, Seasonal / Q000097:blood; D013373:Substance P / Q000378:metabolism*; D014020:Tissue Extracts / Q000494:pharmacology
D004676:Myelin Basic Protein; D010972:Platelet Activating Factor; D014020:Tissue Extracts; D011107:Polylysine; D013373:Substance P; D003571:Cytochalasin B; D009240:N-Formylmethionine Leucyl-Phenylalanine; D011189:Potassium Chloride; D002211:Capsaicin